Trade Summary

3 days ago, Francis Richard D, serving as Pres, CEO at Teva Pharmaceutical Industries Ltd (TEVA), sold 442,935 shares at $32.36 per share, for a total transaction value of $14,333,332.00. Following this transaction, Francis Richard D now holds 1,121,382 shares of TEVA.

This sale represents a 28.00% decrease in Francis Richard D's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 2 days after the trade was made.

Teva Pharmaceutical Industries Ltd operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.